Navigation Links
American Society for Microbiology honors Walter Stamm
Date:7/14/2008

Washington, DCJune 25, 2008 The 2008 American Society for Microbiology (ASM) sanofi-aventis U.S. Award will be presented to Walter Stamm, Associate Director, WWAMI Regional Center of Excellence for Biodefense and Emerging Infectious Diseases, Seattle, Washington. Supported by an unrestricted grant from sanofi-aventis U.S., this award honors outstanding accomplishment in antimicrobial chemotherapy.

Through his professional life, Dr. Stamm has worked with antimicrobial resistance for urinary tract infections, chlamydia infections, and sexually transmitted infections. He is recognized as a leader in the antimicrobial therapy of urinary tract infections and has written guidelines for the therapy of chlamydia and other STIs for the Centers for Disease Control and Prevention. Dr. Stamm has published over 300 peer-reviewed papers, about 100 book chapters, and 11 books, most of them about urinary tract infections and genital infections including the role of bacterial pathogenesis, antimicrobial susceptibility and resistance. From 1999 through 2000, Dr. Stamm was a visiting scientist for the World Health Organization in the Antimicrobial Drug Resistance and Surveillance Branch.

Dr. Stamm received his B.A. in Biological Sciences from Stanford University and his M.D. from Harvard Medical School.. He completed his residency at the University of Washington.

The sanofi-aventis U.S. Award will be presented during ASM's 48th Interscience Conference on Antimicrobial Agents and Chemotherapy/46th IDSA Annual Meeting, October 25 October 28, 2008 in Washington, DC. ASM is the world's oldest and largest life science organization and has more than 43,000 members worldwide. ASM's mission is to advance the microbiological sciences and promote the use of scientific knowledge for improved health and economic and environmental well-being.


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

Page: 1

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Understanding hypertension in African Americans proves elusive
3. Tips from the Journals of the American Society for Microbiology
4. American Chemical Societys Weekly PressPac -- Aug. 15, 2007
5. American College of Medical Genetics responds to new FDA labeling decision for warfarin
6. American Chemical Societys Weekly Press Pac
7. Highlights from the September 2007 Journal of the American Dietetic Association
8. American Chemical Societys Weekly Presspac -- Aug. 29, 2007
9. Report: African, Asian, Latin American farm animals face extinction
10. American Chemical Society calls green chemistry bill a smart step
11. Challenges remain in reintroducing American chestnut
Post Your Comments:
*Name:
*Comment:
*Email:
Other Biology Technology:Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over 2Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over 3Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over 4Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 2Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 3Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 4Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 5Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 6Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 7Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 8Photonic Products Group, Inc. Reports Record Financial Results for FY 2007 9NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update 2NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update 3